V
VRNA
Verona Pharma
This stock has been delisted.
News
Press Releases
Financial Reports
Profile
Reuters·11/20/2025 13:00
Edgewise Therapeutics Appoints Christopher Martin to Board of Directors
Reuters·11/06/2025 12:12
Ligand Pharma Q3 revenue jumps; raises 2025 guidance
Reuters·10/30/2025 10:31
Merck Reports Third-Quarter Sales of $17.3 Billion
Dow Jones·10/07/2025 21:08
*News On Verona Pharma PLC (VRNA) Now Under MRK
NASDAQ·10/07/2025 20:04
VRNA Quantitative Stock Analysis
NASDAQ·10/07/2025 12:27
Merck Rises 13% in a Week: Should You Buy, Sell or Hold the Stock?
TipRanks·10/07/2025 11:29
Verona Pharma Completes Acquisition and Delisting Process
Reuters·10/07/2025 10:45
Merck Completes Acquisition of Verona Pharma, Adding COPD Drug Ohtuvayre to Portfolio
Dow Jones·10/07/2025 10:45
Press Release: Merck Completes Acquisition of -2-
Dow Jones·10/07/2025 10:45
*Merck Completes Acquisition Of Verona Pharma >MRK VRNA
Dow Jones·10/07/2025 10:45
Press Release: Merck Completes Acquisition of Verona Pharma
Seeking Alpha·10/06/2025 20:46
Merck acquisition of Verona Pharma approved by court
TipRanks·10/06/2025 20:25
Verona gets England, Wales high court approval for acquisition by Merck
TipRanks·09/25/2025 08:45
Verona Pharma Shareholders Approve Merck Acquisition
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.